Page last updated: 2024-08-26

glycidyl nitrate and Intestinal Diseases

glycidyl nitrate has been researched along with Intestinal Diseases in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's1 (25.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Addabbo, F; Bettini, S; Cavalcanti, E; Chieppa, M; Delvecchio, FR; Huang, AY; Liou, R; MonsurrĂ², V; Pizarro, TT; Santino, A; Vadrucci, E1
Cao, J; Chen, Q; Cui, F; Gu, YP; Liu, W; Wu, A; Wu, S; Xia, X; Zhang, X1
Kawachi, K; Nakagawa, H; Nakata, T; Tsunooka, N; Yamamoto, Y; Yoshida, M1
Adam, AA; Colman, RW; Janardham, R; Kettner, CA; Majluf-Cruz, A; Sartor, RB; Stadnicki, A1

Other Studies

4 other study(ies) available for glycidyl nitrate and Intestinal Diseases

ArticleYear
Administration of reconstituted polyphenol oil bodies efficiently suppresses dendritic cell inflammatory pathways and acute intestinal inflammation.
    PloS one, 2014, Volume: 9, Issue:2

    Topics: Acute Disease; Alkaloids; Animals; Benzodioxoles; Capsules; Colitis; Dendritic Cells; Dextran Sulfate; Dose-Response Relationship, Drug; Drug Stability; Inflammation; Interleukin-6; Intestinal Diseases; Lipopolysaccharides; Liposomes; Mice; Peptidoglycan; Piperidines; Polyphenols; Polyunsaturated Alkamides; Quercetin; Tumor Necrosis Factor-alpha

2014
Radioprotector WR-2721 and mitigating peptidoglycan synergistically promote mouse survival through the amelioration of intestinal and bone marrow damage.
    Journal of radiation research, 2015, Volume: 56, Issue:2

    Topics: Amifostine; Animals; Bone Marrow Diseases; Drug Synergism; Intestinal Diseases; Male; Mice; Mice, Inbred C57BL; Peptidoglycan; Radiation Injuries; Radiation-Protective Agents; Survival Rate; Treatment Outcome

2015
Pitavastatin prevents intestinal ischemia/reperfusion-induced bacterial translocation and lung injury in atherosclerotic rats with hypoadiponectinemia.
    Surgery, 2009, Volume: 145, Issue:5

    Topics: Adiponectin; Animals; Atherosclerosis; Bacterial Translocation; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Intestinal Diseases; Lung Injury; Male; Nitric Oxide; Peptidoglycan; Quinolines; Rats; Rats, Wistar; Reperfusion Injury

2009
Specific inhibition of plasma kallikrein modulates chronic granulomatous intestinal and systemic inflammation in genetically susceptible rats.
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 1998, Volume: 12, Issue:3

    Topics: Acute-Phase Proteins; Animals; Arthritis; Boron Compounds; Disease Models, Animal; Disease Susceptibility; Enzyme Inhibitors; Factor XI; Female; Granulomatous Disease, Chronic; Humans; Inflammation; Intestinal Diseases; Kallikreins; Kininogens; Oligopeptides; Peptidoglycan; Prekallikrein; Rats; Rats, Inbred Lew

1998